gms | German Medical Science

Background: The quality of guidance used by healthcare profesionals varies widely. A number of tools have been developed to evaluate guideline quality. One of these, AGREE II, is being used within a formal programme to evaluate and accredit processes used by organisations to develop a range of guidance. Experience from this programme will be presented: 36 processes accredited since 2009 3 international applications 35 organisations refining guidance development processes Analysis indicates consistency in accreditation decisions Weakness in rigour of development, scope and purpose, editorial independence and patient and serivce user involvement correlates with a decision not to accredit.

Objectives/goal: To identify strengths and weaknesses in the methodology of creating the evidence basis for guidelines; To share findings on the relative importance and consistency in criteria evaluation, including patient involvement in guideline production; To discuss applicability of the programme to international guidance; To inform the development of standards in guideline development

Target group, suggested audience: Guideline developers, policy makers, clinicians

Names of moderator and invited speakers Gillian Leng, Deputy CEO, NICE Paul Chrisp, Associate Director Accreditation, NICE Stephanie Birtles, Technical Analyst, NICE Ilkka Kunnamo, Editor-in-chief, Duodecim Medical Publications Ltd.

Description of session and speaker topics: Overview of accreditation, and applicability to different guidance processes What accreditation tells us about guideline development processes International collaboration in guidance accreditation: a case study